Publications

1. Varela RB, Boschen SL, Yates N, Houghton T, Blaha CD, Lee KH, Bennet KE, Kouzani AZ, Berk M, Quevedo J, Valvassori SS, Tye SJ. Anti-manic effect of deep brain stimulation of the ventral tegmental area in an animal model of mania induced by methamphetamine. Bipolar Disord. 2024 Jun; 26 (4):376-387 Epub 2024 Apr 01
   View PubMed
2. Sanchez-Ruiz JA, Trevino-Alvarez AM, Zambrano-Lucio M, Lozano Diaz ST, Wang N, Biernacka JM, Tye SJ, Cuellar-Barboza AB. The Wnt signaling pathway in major depressive disorder: A systematic review of human studies. Psychiatry Res. 2024 May 29; 339:115983 [Epub ahead of print]
   View PubMed
3. Parikh SV, Vande Voort JL, Yocum AK, Achtyes E, Goes FS, Nykamp L, Singh B, Lopez-Vives D, Sera CE, Maixner D, Tarnal V, Severe J, Bartek S, Tye SJ, Rico J, Stoppel CJ, Becerra A, Smart L, Miller CR, Frye MA, Greden JF, Bobo WV. Clinical outcomes in the biomarkers of ketamine (Bio-K) study of open-label IV ketamine for refractory depression. J Affect Disord. 2024 Mar 1; 348:143-151 Epub 2023 Dec 22
   View PubMed
4. Nunez NA, Coombes BJ, Beaupre LM, Ozerdem A, Resendez MG, Romo-Nava F, Bond DJ, Veldic M, Singh B, Moore KM, Betcher HK, Kung S, Prieto ML, Fuentes M, Ercis M, Miola A, Sanchez Ruiz JA, Jenkins G, Batzler A, Leung JG, Cuellar-Barboza A, Tye SJ, McElroy SL, Biernacka JM, Frye MA. Pharmacogenomic overlap between antidepressant treatment response in major depression & antidepressant associated treatment emergent mania in bipolar disorder. Transl Psychiatry. 2024 Feb 13; 14 (1):93
   View PubMed
5. Singh B, Vande Voort JL, Riva-Posse P, Pazdernik VM, Frye MA, Tye SJ. Ketamine-Associated Change in Anhedonia and mTOR Expression in Treatment-Resistant Depression. Biol Psychiatry 2023 Jun 15; 93 (12):e65-e68 Epub 2023 Jan 25
   View PubMed
6. Gardea-Resendez M, Coombes BJ, Veldic M, Tye SJ, Romo-Nava F, Ozerdem A, Prieto ML, Cuellar-Barboza A, Nunez NA, Singh B, Pendegraft RS, Miola A, McElroy SL, Biernacka JM, Morava E, Kozicz T, Frye MA. Antidepressants that increase mitochondrial energetics may elevate risk of treatment-emergent mania. Mol Psychiatry. 2023 Mar; 28 (3):1020-1026 Epub 2022 Dec 13
   View PubMed
7. Yuen J, Goyal A, Rusheen AE, Kouzani AZ, Berk M, Kim JH, Tye SJ, Blaha CD, Bennet KE, Lee KH, Shin H, Oh Y. High frequency deep brain stimulation can mitigate the acute effects of cocaine administration on tonic dopamine levels in the rat nucleus accumbens. Front Neurosci. 2023; 17:1061578 Epub 2023 Jan 30
   View PubMed
8. Yuen J, Goyal A, Rusheen AE, Kouzani AZ, Berk M, Kim JH, Tye SJ, Abulseoud OA, Oesterle TS, Blaha CD, Bennet KE, Lee KH, Oh Y, Shin H. Oxycodone-induced dopaminergic and respiratory effects are modulated by deep brain stimulation. Front Pharmacol. 2023; 14:1199655 Epub 2023 June 20
   View PubMed
9. Lee SYH, Yates NJ, Tye SJ. Inflammatory Mechanisms in Parkinson's Disease: From Pathogenesis to Targeted Therapies. Neuroscientist. 2022 Oct; 28 (5):485-506 Epub 2021 Feb 13
   View PubMed
10. Kruse JL, Boyle CC, Olmstead R, Breen EC, Tye SJ, Eisenberger NI, Irwin MR. Interleukin-8 and depressive responses to an inflammatory challenge: secondary analysis of a randomized controlled trial. Sci Rep. 2022 Jul 24; 12 (1):12627 Epub 2022 July 24
    View PubMed
11. Yuen J, Kouzani AZ, Berk M, Tye SJ, Rusheen AE, Blaha CD, Bennet KE, Lee KH, Shin H, Kim JH, Oh Y. Deep Brain Stimulation for Addictive Disorders-Where Are We Now? Neurotherapeutics. 2022 Jul; 19 (4):1193-1215 Epub 2022 Apr 11
    View PubMed
12. Varela RB, Cararo JH, Tye SJ, Carvalho AF, Valvassori SS, Fries GR, Quevedo J. Contributions of epigenetic inheritance to the predisposition of major psychiatric disorders: Theoretical framework, evidence, and implications. Neurosci Biobehav Rev. 2022 Apr; 135:104579 Epub 2022 Feb 12
    View PubMed
13. Yuen J, Goyal A, Rusheen AE, Kouzani AZ, Berk M, Kim JH, Tye SJ, Blaha CD, Bennet KE, Lee KH, Oh Y, Shin H. Cocaine increases stimulation-evoked serotonin efflux in the nucleus accumbens. J Neurophysiol. 2022 Mar 1; 127 (3):714-724 Epub 2022 Jan 05
    View PubMed
14. Tye SJ, Borreggine K, Price JB, Sutor SL, Cuellar-Barboza AB, McElroy SL, Biernacka JM, Frye MA. Dynamic insulin-stimulated mTOR/GSK3 signaling in peripheral immune cells: Preliminary evidence for an association with lithium response in bipolar disorder. Bipolar Disord. 2022 Feb; 24 (1):39-47 Epub 2021 May 13
    View PubMed
15. Price JB, Yates CG, Morath BA, Van De Wakker SK, Yates NJ, Butters K, Frye MA, McGee SL, Tye SJ. Lithium augmentation of ketamine increases insulin signaling and antidepressant-like active stress coping in a rodent model of treatment-resistant depression. Transl Psychiatry. 2021 Nov 25; 11 (1):598
    View PubMed
16. Kruse JL, Olmstead R, Hellemann G, Breen EC, Tye SJ, Brooks JO 3rd, Wade B, Congdon E, Espinoza R, Narr KL, Irwin MR. Interleukin-8 and lower severity of depression in females, but not males, with treatment-resistant depression. J Psychiatr Res. 2021 Aug; 140:350-356 Epub 2021 June 09
    View PubMed
17. Kale RP, Nguyen TTL, Price JB, Yates NJ, Walder K, Berk M, Sillitoe RV, Kouzani AZ, Tye SJ. Mood Regulatory Actions of Active and Sham Nucleus Accumbens Deep Brain Stimulation in Antidepressant Resistant Rats. Front Hum Neurosci. 2021; 15:644921 Epub 2021 July 19
    View PubMed
18. Yuen J, Goyal A, Rusheen AE, Kouzani AZ, Berk M, Kim JH, Tye SJ, Blaha CD, Bennet KE, Jang DP, Lee KH, Shin H, Oh Y. Cocaine-Induced Changes in Tonic Dopamine Concentrations Measured Using Multiple-Cyclic Square Wave Voltammetry in vivo. Front Pharmacol. 2021; 12:705254 Epub 2021 July 06
    View PubMed
19. Shiroma PR, Thuras P, Wels J, Albott CS, Erbes C, Tye S, Lim KO. Neurocognitive performance of repeated versus single intravenous subanesthetic ketamine in treatment resistant depression. J Affect Disord. 2020 Dec 1; 277:470-477 Epub 2020 Aug 26
    View PubMed
20. Shiroma PR, Thuras P, Wels J, Albott CS, Erbes C, Tye S, Lim KO. A randomized, double-blind, active placebo-controlled study of efficacy, safety, and durability of repeated vs single subanesthetic ketamine for treatment-resistant depression. Transl Psychiatry. 2020 Jun 26; 10 (1):206 Epub 2020 June 26
    View PubMed
21. Varela RB, Resende WR, Dal-Pont GC, Gava FF, Tye SJ, Quevedo J, Valvassori SS. HDAC inhibitors reverse mania-like behavior and modulate epigenetic regulatory enzymes in an animal model of mania induced by Ouabain. Pharmacol Biochem Behav. 2020 Jun; 193:172917 Epub 2020 Mar 25
    View PubMed
22. Seshadri A, Clark MM, Kung S, Fuller-Tyszkiewicz M, Sood A, Dammen KC, Rico JA, Tye SJ, McGillivray J, Frye MA. Feasibility Study of Stress Management and Resiliency Training (SMART) in Patients With Major Depressive Disorder. Prim Care Companion CNS Disord. 2020 Apr 30; 22 (3)
    View PubMed
23. Adams SD, Doeven EH, Tye SJ, Bennet KE, Berk M, Kouzani AZ. TinyFSCV: FSCV for the Masses. IEEE Trans Neural Syst Rehabil Eng. 2020 Jan; 28 (1):133-142 Epub 2019 Nov 28
    View PubMed
24. Walker AJ, Price JB, Borreggine K, Sutor SL, Gogos A, McGillivray JA, Frye MA, Tye SJ. Insulin-stimulated mTOR activation in peripheral blood mononuclear cells associated with early treatment response to lithium augmentation in rodent model of antidepressant-resistance. Transl Psychiatry. 2019 Mar 15; 9 (1):113
    View PubMed
25. Adams SD, Bennet KE, Tye SJ, Berk M, Kouzani AZ. Development of a miniature device for emerging deep brain stimulation paradigms. PLoS One. 2019; 14 (2):e0212554 Epub 2019 Feb 21
    View PubMed
26. Ahmed AT, Frye MA, Rush AJ, Biernacka JM, Craighead WE, McDonald WM, Bobo WV, Riva-Posse P, Tye SJ, Mayberg HS, Hall-Flavin DK, Skime MK, Jenkins GD, Wang L, Krishnan RR, Weinshilboum RM, Kaddurah-Daouk R, Dunlop BW, Mood Disorders Precision Medicine Consortium (MDPMC). Mapping depression rating scale phenotypes onto research domain criteria (RDoC) to inform biological research in mood disorders. J Affect Disord. 2018 Oct 1; 238:1-7 Epub 2018 May 26
    View PubMed
27. Cullen KR, Amatya P, Roback MG, Albott CS, Westlund Schreiner M, Ren Y, Eberly LE, Carstedt P, Samikoglu A, Gunlicks-Stoessel M, Reigstad K, Horek N, Tye S, Lim KO, Klimes-Dougan B. Intravenous Ketamine for Adolescents with Treatment-Resistant Depression: An Open-Label Study. J Child Adolesc Psychopharmacol. 2018 Sep; 28 (7):437-444 Epub 2018 July 13
    View PubMed
28. Nguyen TTL, Chan LC, Borreginne K, Kale RP, Hu C, Tye SJ. A review of brain insulin signaling in mood disorders: From biomarker to clinical target. Neurosci Biobehav Rev. 2018 Sep; 92:7-15 Epub 2018 May 26
    View PubMed
29. Price JB, Bronars C, Erhardt S, Cullen KR, Schwieler L, Berk M, Walder K, McGee SL, Frye MA, Tye SJ. Bioenergetics and synaptic plasticity as potential targets for individualizing treatment for depression. Neurosci Biobehav Rev. 2018 Jul; 90:212-220 Epub 2018 Apr 12
    View PubMed
30. Yang J, Lopez Cervera R, Tye SJ, Ekker SC, Pierret C. Adolescent mental health education InSciEd Out: a case study of an alternative middle school population. J Transl Med. 2018 Apr 3; 16 (1):84 Epub 2018 Apr 03
    View PubMed
31. Edward ES, Kouzani AZ, Tye SJ. Towards miniaturized closed-loop optogenetic stimulation devices. J Neural Eng. 2018 Apr; 15 (2):021002
    View PubMed
32. Adams SD, Kouzani AZ, Tye SJ, Bennet KE, Berk M. An investigation into closed-loop treatment of neurological disorders based on sensing mitochondrial dysfunction. J Neuroeng Rehabil. 2018 Feb 13; 15 (1):8
    View PubMed
33. Brimijoin S, Tye S. Favorable Impact on Stress-Related Behaviors by Modulating Plasma Butyrylcholinesterase. Cell Mol Neurobiol. 2018 Jan; 38 (1):7-12 Epub 2017 July 15
    View PubMed
34. Kouzani AZ, Kale RP, Zarate-Garza PP, Berk M, Walder K, Tye SJ. Validation of a Portable Low-Power Deep Brain Stimulation Device Through Anxiolytic Effects in a Laboratory Rat Model. IEEE Trans Neural Syst Rehabil Eng. 2017 Sep; 25 (9):1365-1374 Epub 2016 Nov 15
    View PubMed
35. Luthar SS, Curlee A, Tye SJ, Engelman JC, Stonnington CM. Fostering Resilience among Mothers under Stress: "Authentic Connections Groups" for Medical Professionals. Womens Health Issues. 2017 May - Jun; 27 (3):382-390 Epub 2017 Apr 14
    View PubMed
36. Morris G, Walder K, McGee SL, Dean OM, Tye SJ, Maes M, Berk M. A model of the mitochondrial basis of bipolar disorder. Neurosci Biobehav Rev. 2017 Mar; 74 (Pt A):1-20 Epub 2017 Jan 14
    View PubMed
37. Zarate-Garza PP, Biggs BK, Croarkin P, Morath B, Leffler J, Cuellar-Barboza A, Tye SJ. How Well Do We Understand the Long-Term Health Implications of Childhood Bullying? Harv Rev Psychiatry. 2017 Mar/Apr; 25 (2):89-95
    View PubMed
38. Patten CA, Bronars CA, Vickers Douglas KS, Ussher MH, Levine JA, Tye SJ, Hughes CA, Brockman TA, Decker PA, DeJesus RS, Williams MD, Olson TP, Clark MM, Dieterich AM. Supervised, Vigorous Intensity Exercise Intervention for Depressed Female Smokers: A Pilot Study. Nicotine Tob Res. 2017 Jan; 19 (1):77-86 Epub 2016 Sept 09
    View PubMed
39. Vande Voort JL, Morgan RJ, Kung S, Rasmussen KG, Rico J, Palmer BA, Schak KM, Tye SJ, Ritter MJ, Frye MA, Bobo WV. Continuation phase intravenous ketamine in adults with treatment-resistant depression. J Affect Disord. 2016 Dec; 206:300-304. Epub 2016 Sep 12.
    View PubMed
40. Berk M, Tye S, Walder K, McGee S. Hyperthermia for Major Depressive Disorder? JAMA Psychiatry 2016 Oct 1; 73 (10):1095-1096
    View PubMed
41. Bobo WV, Vande Voort JL, Croarkin PE, Leung JG, Tye SJ, Frye MA. KETAMINE FOR TREATMENT-RESISTANT UNIPOLAR AND BIPOLAR MAJOR DEPRESSION: CRITICAL REVIEW AND IMPLICATIONS FOR CLINICAL PRACTICE. Depress Anxiety. 2016 Aug; 33 (8):698-710 Epub 2016 Apr 06
    View PubMed
42. Parastarfeizabadi M, Kouzani AZ, Gibson I, Tye SJ. A miniature closed-loop deep brain stimulation device. Conf Proc IEEE Eng Med Biol Soc. 2016 Aug; 2016:1786-1789.
    View PubMed
43. Edward ES, Kouzani AZ, Kale RP, Tye SJ. Portable closed-loop optogenetic stimulation device. Conf Proc IEEE Eng Med Biol Soc. 2016 Aug; 2016:5250-5253.
    View PubMed
44. Veerabhadrappa R, Lim CP, Nguyen TT, Berk M, Tye SJ, Monaghan P, Nahavandi S, Bhatti A. Unified selective sorting approach to analyse multi-electrode extracellular data. Sci Rep. 2016 Jun 24; 6:28533 Epub 2016 June 24
    View PubMed
45. Kim Y, McGee S, Czeczor JK, Walker AJ, Kale RP, Kouzani AZ, Walder K, Berk M, Tye SJ. Nucleus accumbens deep-brain stimulation efficacy in ACTH-pretreated rats: alterations in mitochondrial function relate to antidepressant-like effects. Transl Psychiatry. 2016 Jun 21; 6 (6):e842 Epub 2016 June 21
    View PubMed
46. Adams S, Kouzani AZ, Mohammed M, Usma C, Tye SJ. Fabrication of Biocompatible Enclosures for an Electronic Implant Using 3D printing Int. J. Raid Manufacturing.2016;
    
47. Kim Y, Morath B, Hu C, Byrne LK, Sutor SL, Frye MA, Tye SJ. Antidepressant actions of lateral habenula deep brain stimulation differentially correlate with CaMKII/GSK3/AMPK signaling locally and in the infralimbic cortex. Behav Brain Res. 2016 Jun 1; 306:170-7 Epub 2016 Mar 05
    View PubMed
48. Edward ES, Kouzani AZ, Berk J, Tye SJ. A miniature neural recording device Proceedings of the IEEE International Conference on Industrial Technology. 2016; 2016-May:1012-5.
    
49. Abulseoud OA, Kasasbeh A, Min HK, Fields JA, Tye SJ, Goerss S, Knight EJ, Sampson SM, Klassen BT, Matsumoto JY, Stoppel C, Lee KH, Frye MA. Stimulation-Induced Transient Nonmotor Psychiatric Symptoms following Subthalamic Deep Brain Stimulation in Patients with Parkinson's Disease: Association with Clinical Outcomes and Neuroanatomical Correlates. Stereotact Funct Neurosurg. 2016; 94 (2):93-101 Epub 2016 Apr 20
    View PubMed
50. Hosain MK, Kouzani AZ, Tye SJ, Samad MF, Kale RP, Bennet KE, Manciu FS, Berk M. Radio frequency energy harvesting from a feeding source in a passive deep brain stimulation device for murine preclinical research. Med Eng Phys. 2015 Oct; 37 (10):1020-6 Epub 2015 Aug 28
    View PubMed
51. Kale RP, Kouzani AZ, Walder K, Berk M, Tye SJ. Evolution of optogenetic microdevices. Neurophotonics. 2015 Jul; 2 (3):031206 Epub 2015 June 25
    View PubMed
52. Hosain MK, Kouzani AZ, Samad MSTF, Tye SJ. A miniature energy harvesting rectenna for operating a head-mountable deep brain stimulation device Ieee Access. 2015; 3:223-34.
    
53. Veerabhadrappa R, Bhatti A, Lim CP, Nguyen TT, Tye SJ, Monaghan P, Nahavandi S. Statistical modelling of artificial neural network for sorting temporally synchronous spikes Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics). 2015; 9491:261-72.
    
54. Tye S, Van Voorhees E, Hu C, Lineberry T. Preclinical perspectives on posttraumatic stress disorder criteria in DSM-5. Harv Rev Psychiatry. 2015 Jan-Feb; 23 (1):51-8
    View PubMed
55. Frye MA, Prieto ML, Bobo WV, Kung S, Veldic M, Alarcon RD, Moore KM, Choi DS, Biernacka JM, Tye SJ. Current landscape, unmet needs, and future directions for treatment of bipolar depression. J Affect Disord. 2014 Dec; 169 Suppl 1:S17-23
    View PubMed
56. Holland BJ, Conlan XA, Stevenson PG, Tye S, Reker A, Barnett NW, Adcock JL, Francis PS. Determination of neurotransmitters and their metabolites using one- and two-dimensional liquid chromatography with acidic potassium permanganate chemiluminescence detection. Anal Bioanal Chem. 2014 Sep; 406(23):5669-76.
    
57. Hosain MD, Kouzani AZ, Tye SJ, Abulseoud OA, Amiet A, Galehdar A, Kaynak A, Berk M. Development of a Compact Rectenna for Wireless Powering of a Head-Mountable Deep Brain Stimulation Device. IEEE J Transl Eng Health Med. 2014; 2:1500113.
    View PubMed
58. Hosain MK, Kouzani A, Tye S. Closed loop deep brain stimulation: an evolving technology. Australas Phys Eng Sci Med. 2014; 37(4):619-34.
    View PubMed
59. Adams S, Kouzani AZ, Kale R, Tye SJ. A Miniature Low-power Adjustable Constant-voltage Deep Brain Stimulation Device. Proceedings of ICME International Conference on Complex Medical Engineering. 2014.
    
60. Walker AJ, Kim Y, Price JB, Kale RP, McGillivray JA, Berk M, Tye SJ. Stress, Inflammation, and Cellular Vulnerability during Early Stages of Affective Disorders: Biomarker Strategies and Opportunities for Prevention and Intervention. Front Psychiatry. 2014; 5:34 Epub 2014 Apr 09
    View PubMed
61. Broadbent J, Sitka N, Macfarlane S, McGillivray J, Tye S. Informing Brain Health Behaviour Choices: The efficacy of a High-School Brain Awareness pilot study. British Journal of Education Society & Behavioural Science 06/. 2014; 4(6):755-767.
    
62. Kouzani AZ, Abulseoud OA, Tye SJ, Hosain MD, Berk M. A Low Power Micro Deep Brain Stimulation Device for Murine Preclinical Research. IEEE J Transl Eng Health Med. 2013; 2:1500109 Epub 2013 June 04
    View PubMed
63. Tye SJ, Miller AD, Blaha CD. Ventral tegmental glutamate receptor stimulation of nucleus accumbens tonic dopamine efflux blunts hindbrain-evoked phasic neurotransmission: Implications for dopamine dysregulation disorders. Neuroscience. 2013; 252C:337-345.
    
64. Hosain MK, Kouzani AZ, Tye SJ, Abulseoud OA, Berk M. Design and analysis of an antenna for wireless energy harvesting in a head-mountable DBS device. Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBS. 2013; 3078-81.
    
65. Chopra A, Tye SJ, Lee KH, Sampson S, Matsumoto J, Adams A, Klassen B, Stead M, Fields JA, Frye MA. Underlying neurobiology and clinical correlates of mania status after subthalamic nucleus deep brain stimulation in Parkinson's disease: a review of the literature. J Neuropsychiatry Clin Neurosci. 2012 Winter; 24 (1):102-10
    View PubMed
66. Griessenauer CJ, Chang SY, Tye SJ, Kimble CJ, Bennet KE, Garris PA, Lee KH. Wireless Instantaneous Neurotransmitter Concentration System: electrochemical monitoring of serotonin using fast-scan cyclic voltammetry--a proof-of-principle study. J Neurosurg. 2010 Sep; 113 (3):656-65
    View PubMed
67. Tye SJ, van Rooy W, Pollard I. Drug and Alcohol Use, Sexual Intimacy and Associated Health Status of Senior High School Students. Eubios Journal of Asian & International Bioethics.. 2010 May 7;
    
68. Shon YM, Chang SY, Tye SJ, Kimble CJ, Bennet KE, Blaha CD, Lee KH. Comonitoring of adenosine and dopamine using the Wireless Instantaneous Neurotransmitter Concentration System: proof of principle. J Neurosurg. 2010 Mar; 112 (3):539-48
    View PubMed
69. Tye SJ, Miller AD, Blaha CD. Differential corticosteroid receptor regulation of mesoaccumbens dopamine efflux during the peak and nadir of the circadian rhythm: a molecular equilibrium in the midbrain? Synapse. 2009 Nov; 63 (11):982-90
    View PubMed
70. Agnesi F, Tye SJ, Bledsoe JM, Griessenauer CJ, Kimble CJ, Sieck GC, Bennet KE, Garris PA, Blaha CD, Lee KH. Wireless Instantaneous Neurotransmitter Concentration System-based amperometric detection of dopamine, adenosine, and glutamate for intraoperative neurochemical monitoring. J Neurosurg. 2009 Oct; 111 (4):701-11
    View PubMed
71. Tye SJ, Frye MA, Lee KH. Disrupting disordered neurocircuitry: treating refractory psychiatric illness with neuromodulation. Mayo Clin Proc. 2009 Jun; 84 (6):522-32
    View PubMed
72. Kimble CJ, Johnson DM, Winter BA, Whitlock SV, Kressin KR, Horne AE, Robinson JC, Bledsoe JM, Tye SJ, Chang SY, Agnesi F, Griessenauer CJ, Covey D, Shon YM, Bennet KE, Garris PA, Lee KH. Wireless Instantaneous Neurotransmitter Concentration Sensing System (WINCS) for intraoperative neurochemical monitoring. Annu Int Conf IEEE Eng Med Biol Soc. 2009; 2009:4856-9
    View PubMed